Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nautilus Biotechnology Inc.
NAUT | US
2.62
USD0.04
1.55%
NAUT | US
Loading StockChartView...
About Nautilus Biotechnology Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
2.62
Open
2.62
High
2.71
Low
2.53
Nautilus Biotechnology Inc. a development stage life sciences company engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform a proteomics platform that includes end-to-end solution comprised of instruments consumables and software analysis. The company was incorporated in 2016 and is headquartered in Seattle Washington.
View LessNAUT | US
Risk
89.5
Sharpe
2.33
Luna's Score
55/100
Recommendation
Hold
Luna says (NAUT | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
74.7%1 month
89.5%3 months
108.1%6 months
118.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.53
Debt to equity
0.14
Debt to assets
0.12
Ent. to EBITDA
-2.00
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-79.42M
MarketCap
328.58M
MarketCap(USD)
328.58M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-26.53
Short ratio
13.56
Short perc.
2.90
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.75
Range1M
1.78
Range3M
2.44
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.79
Price X volume
738.37K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.00 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.53 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 108.06 | 72.80 | Riskier |
| Debt to Equity | 0.14 | -1.23 | Expensive |
| Debt to Assets | 0.12 | 0.25 | Cheaper |
| Market Cap | 328.58M | 3.66B | Emerging |
